Literature DB >> 33901527

Deep Learning Estimation of 10-2 and 24-2 Visual Field Metrics Based on Thickness Maps from Macula OCT.

Mark Christopher1, Christopher Bowd1, James A Proudfoot1, Akram Belghith1, Michael H Goldbaum1, Jasmin Rezapour2, Massimo A Fazio3, Christopher A Girkin3, Gustavo De Moraes4, Jeffrey M Liebmann4, Robert N Weinreb1, Linda M Zangwill5.   

Abstract

PURPOSE: To develop deep learning (DL) systems estimating visual function from macula-centered spectral-domain (SD) OCT images.
DESIGN: Evaluation of a diagnostic technology. PARTICIPANTS: A total of 2408 10-2 visual field (VF) SD OCT pairs and 2999 24-2 VF SD OCT pairs collected from 645 healthy and glaucoma subjects (1222 eyes).
METHODS: Deep learning models were trained on thickness maps from Spectralis macula SD OCT to estimate 10-2 and 24-2 VF mean deviation (MD) and pattern standard deviation (PSD). Individual and combined DL models were trained using thickness data from 6 layers (retinal nerve fiber layer [RNFL], ganglion cell layer [GCL], inner plexiform layer [IPL], ganglion cell-IPL [GCIPL], ganglion cell complex [GCC] and retina). Linear regression of mean layer thicknesses were used for comparison. MAIN OUTCOME MEASURES: Deep learning models were evaluated using R2 and mean absolute error (MAE) compared with 10-2 and 24-2 VF measurements.
RESULTS: Combined DL models estimating 10-2 achieved R2 of 0.82 (95% confidence interval [CI], 0.68-0.89) for MD and 0.69 (95% CI, 0.55-0.81) for PSD and MAEs of 1.9 dB (95% CI, 1.6-2.4 dB) for MD and 1.5 dB (95% CI, 1.2-1.9 dB) for PSD. This was significantly better than mean thickness estimates for 10-2 MD (0.61 [95% CI, 0.47-0.71] and 3.0 dB [95% CI, 2.5-3.5 dB]) and 10-2 PSD (0.46 [95% CI, 0.31-0.60] and 2.3 dB [95% CI, 1.8-2.7 dB]). Combined DL models estimating 24-2 achieved R2 of 0.79 (95% CI, 0.72-0.84) for MD and 0.68 (95% CI, 0.53-0.79) for PSD and MAEs of 2.1 dB (95% CI, 1.8-2.5 dB) for MD and 1.5 dB (95% CI, 1.3-1.9 dB) for PSD. This was significantly better than mean thickness estimates for 24-2 MD (0.41 [95% CI, 0.26-0.57] and 3.4 dB [95% CI, 2.7-4.5 dB]) and 24-2 PSD (0.38 [95% CI, 0.20-0.57] and 2.4 dB [95% CI, 2.0-2.8 dB]). The GCIPL (R2 = 0.79) and GCC (R2 = 0.75) had the highest performance estimating 10-2 and 24-2 MD, respectively.
CONCLUSIONS: Deep learning models improved estimates of functional loss from SD OCT imaging. Accurate estimates can help clinicians to individualize VF testing to patients.
Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep learning; Glaucoma; OCT; Structure-function; Visual field

Mesh:

Year:  2021        PMID: 33901527     DOI: 10.1016/j.ophtha.2021.04.022

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   14.277


  5 in total

1.  A Case for the Use of Artificial Intelligence in Glaucoma Assessment.

Authors:  Joel S Schuman; Maria De Los Angeles Ramos Cadena; Rebecca McGee; Lama A Al-Aswad; Felipe A Medeiros
Journal:  Ophthalmol Glaucoma       Date:  2021-12-22

2.  Machine learning-based 3D modeling and volumetry of human posterior vitreous cavity of optical coherence tomographic images.

Authors:  Hiroyuki Takahashi; Zaixing Mao; Ran Du; Kyoko Ohno-Matsui
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

Review 3.  Applications of natural language processing in ophthalmology: present and future.

Authors:  Jimmy S Chen; Sally L Baxter
Journal:  Front Med (Lausanne)       Date:  2022-08-08

Review 4.  The Development and Clinical Application of Innovative Optical Ophthalmic Imaging Techniques.

Authors:  Palaiologos Alexopoulos; Chisom Madu; Gadi Wollstein; Joel S Schuman
Journal:  Front Med (Lausanne)       Date:  2022-06-30

5.  Deepfakes in Ophthalmology: Applications and Realism of Synthetic Retinal Images from Generative Adversarial Networks.

Authors:  Jimmy S Chen; Aaron S Coyner; R V Paul Chan; M Elizabeth Hartnett; Darius M Moshfeghi; Leah A Owen; Jayashree Kalpathy-Cramer; Michael F Chiang; J Peter Campbell
Journal:  Ophthalmol Sci       Date:  2021-11-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.